Skip to main content

马里兰州医疗学会选定PRA Health Sciences提供远程患者监测和远程医疗服务

Written by Customer Service on . Posted in Public Companies.

北卡罗来纳州罗利和马里兰州巴尔的摩, April 23, 2021 (GLOBE NEWSWIRE) — PRA Health Sciences（NASDAQ：PRAH）和马里兰州医疗协会（Maryland State Medical Society，即：MedChi）今天宣布，PRA Health Sciences旗下公司 Care Innovations已被MedChi选定为远程患者监护、远程医疗和数字健康服务的首选提供商，为该协会网络中执业范围超过50个医疗专业的2.2万多名注册医生提供相关服务。马里兰州医生现在拥有了一家值得信赖的提供商，可快速部署安全且符合隐私要求的系统来进行远程患者护理，包括常规访视和慢性疾病管理。

MedChi首席执行官Gene Ransom表示，“通过RPM来管理患者医疗护理工作，现在正当其时。当前疫情已经证明了远程患者监护的临床和经济效益，而医生们也正在寻找合适的供应商来支持这种长期的虚拟模式。MedChi很高兴能帮助医生们快速选择一家全面的提供商，并扩大患者获得这些重要服务的渠道。”

远程患者监护是医疗保健的重要组成部分，有助于改善患者疗效和提高患者满意度。通过以自动远程方式捕获医疗信息，RPM可提供全面的、以患者为中心的医疗护理，特别是针对老年人和高危患者。在当今疫情环境中，RPM在无需患者离家的情况下即可评估其健康信息，有助于患者避免感染新冠肺炎，并减少急诊和住院次数。

选择Care Innovations后，医生将获得面向医生和患者的技术，包括远程患者监测平台、Health Harmony移动应用、护士主导的协调中心和连接互联网的设备，如血压袖带、脉搏血氧仪和血糖仪。患者可以使用这些医疗设备和移动应用居家管理其医疗护理，而医生则可以远程监控相关数据。此外，医生还可以选择月度医护管理方法，以便针对符合要求的患者开具Medicare CPT RPM规范相关的服务账单。

PRA Health Sciences高级副总裁兼Care Innovations总裁Randy Swanson表示：“远程患者监测和远程医疗为医生提供了一种创新方法，以近实时方式监测患者健康状况，并且不受旅行或时间限制。PRA的数字健康解决方案提供了基础设施、技术和支付方补偿计划，以支持医生的执业要求和患者的医疗需求。”

马里兰州医生如需了解更多信息或立即注册这些服务，可访问CareInnovations.com或MedChi page。

关于PRA Health Sciences

按营业收入计，PRA Health Sciences是世界最大的全球合同研究机构之一，为生物技术和制药行业提供外包临床研发和数据解决方案服务。PRA的全球临床研发平台遍及北美、欧洲、亚洲、拉丁美洲、非洲、澳大利亚和中东，办公机构达到75个以上，在全球拥有超过1.9万名员工。自2000年以来，PRA已参与了世界各地约4000项临床试验。此外，PRA还参与了众多关键性或支持性试验，超过95种产品由此获得了美国食品药品管理局和国际监管机构批准。如需了解有关PRA的更多信息，请访问www.prahs.com。

投资者关系咨询：InvestorRelations@prahs.com

媒体咨询：Laurie Hurst, Sr. 传播和公共关系总监
hurstlaurie@prahs.com | +1 (919) 786-8435

关于马里兰州医疗协会

MedChi，即马里兰州医疗协会，是马里兰州医生的非营利性会员协会。该协会是马里兰州最大的医生组织。MedChi的使命是成为马里兰州医生、患者和该州公共卫生事业的首要倡导者和资源。如需更多信息，请访问：www.medchi.org。

 

Disclaimer & Cookie Notice

Welcome to GOLDEA services for Professionals

Before you continue, please confirm the following:

Professional advisers only

I am a professional adviser and would like to visit the GOLDEA CAPITAL for Professionals website.

Important Notice for Investors:

The services and products offered by Goldalea Capital Ltd. are intended exclusively for professional market participants as defined by applicable laws and regulations. This typically includes institutional investors, qualified investors, and high-net-worth individuals who have sufficient knowledge, experience, resources, and independence to assess the risks of trading on their own.

No Investment Advice:

The information, analyses, and market data provided are for general information purposes only and do not constitute individual investment advice. They should not be construed as a basis for investment decisions and do not take into account the specific investment objectives, financial situation, or individual needs of any recipient.

High Risks:

Trading in financial instruments is associated with significant risks and may result in the complete loss of the invested capital. Goldalea Capital Ltd. accepts no liability for losses incurred as a result of the use of the information provided or the execution of transactions.

Sole Responsibility:

The decision to invest or not to invest is solely the responsibility of the investor. Investors should obtain comprehensive information about the risks involved before making any investment decision and, if necessary, seek independent advice.

No Guarantees:

Goldalea Capital Ltd. makes no warranties or representations as to the accuracy, completeness, or timeliness of the information provided. Markets are subject to constant change, and past performance is not a reliable indicator of future results.

Regional Restrictions:

The services offered by Goldalea Capital Ltd. may not be available to all persons or in all countries. It is the responsibility of the investor to ensure that they are authorized to use the services offered.

Please note: This disclaimer is for general information purposes only and does not replace individual legal or tax advice.